Osaka, Japan

Kazuho Kohashi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuho Kohashi. Retrieved from https://idiyas.com/inventor/kazuho-kohashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuho Kohashi: Innovator in Bactericides

Introduction

Kazuho Kohashi is a notable inventor based in Osaka, Japan. She has made significant contributions to the field of bactericides, particularly with her innovative compounds that target resistant strains of bacteria. Her work is crucial in the ongoing battle against infectious diseases.

Latest Patents

Kazuho Kohashi holds a patent for a novel compound known as 6,7-dihydroimidazo[2,1-b][1,3]oxazine. This compound exhibits excellent bactericidal action against tubercle bacilli, multidrug-resistant tubercle bacilli, and atypical acid-fast bacilli. The invention provides a compound represented by Formula (1) or a salt thereof, showcasing its potential in medical applications.

Career Highlights

Kohashi is affiliated with Otsuka Pharmaceutical Company, Limited, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and treatment of bacterial infections.

Collaborations

Kazuho Kohashi has collaborated with esteemed colleagues such as Yoshikazu Kawano and Yoshikazu Haraguchi. These partnerships have fostered innovation and enhanced the impact of her research in the pharmaceutical industry.

Conclusion

Kazuho Kohashi's contributions to bactericides highlight her role as a leading inventor in the field. Her innovative work continues to pave the way for advancements in medical treatments against resistant bacterial strains.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…